Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2013; 19(34): 5678-5684
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5678
Table 1 Demographic and clinical data of patients and controls
APSevere APMild APControl
Age, mean ± SD, yr48.1 ± 15.550.2 ± 13.746.7 ± 16.842.07 ± 16.6
Men68%64%70%33%
AP etiology
Alcoholic35%36%35%NA
Nonalcoholic65%64%65%NA
Death6%7%5%NA
Table 2 Percentages of saturated, monounsaturated and polyunsaturated fatty acids in erythrocyte membrane phospholipids
APAlcoholic APNonalcoholic APControl
Saturated fatty acid
C14:00.26 ± 0.060.26 ± 0.060.26 ± 0.070.27 ± 0.06
C15:00.29 ± 0.050.27 ± 0.040.30 ± 0.060.30 ± 0.05
C16:023.43 ± 1.12b23.80 ± 1.20b23.22 ± 1.06b22.17 ± 0.85
C17:00.27 ± 0.06b0.23 ± 0.03b0.29 ± 0.060.31 ± 0.03
C18:013.49 ± 0.70a13.40 ± 0.5413.54 ± 0.7813.95 ± 0.70
C20:00.33 ± 0.10b0.28 ± 0.06b0.36 ± 0.090.40 ± 0.06
C21:00.04 ± 0.040.04 ± 0.060.04 ± 0.040.03 ± 0.03
C22:01.39 ± 0.331.15 ± 0.23b1.47 ± 0.341.44 ± 0.26
C23:00.21 ± 0.06a0.17 ± 0.04b0.23 ± 0.060.24 ± 0.04
C24:04.44 ± 0.804.30 ± 0.774.41 ± 0.974.10 ± 0.73
Total44.05 ± 1.47a43.90 ± 1.0044.13 ± 1.7043.34 ± 0.90
Monounsaturated fatty acid
C16:1n7trans0.13 ± 0.020.12 ± 0.020.13 ± 0.020.14 ± 0.02
C16:1n9c0.09 ± 0.06b0.09 ± 0.030.09 ± 0.070.06 ± 0.03
C16:1n7c0.56 ± 0.19b0.68 ± 0.17b0.49 ± 0.17b0.33 ± 0.06
C18:1n9trans0.11 ± 0.05b0.10 ± 0.02b0.12 ± 0.06a0.16 ± 0.04
C18:1n7trans0.28 ± 0.09a0.23 ± 0.07b0.30 ± 0.090.33 ± 0.09
C18:1n9c13.02 ± 1.4913.53 ± 1.05a12.85 ± 1.8812.42 ± 1.12
C18:1n7c1.08 ± 0.171.09 ± 0.151.07 ± 0.201.03 ± 0.13
C22:1n9c0.22 ± 0.05a0.23 ± 0.06a0.22 ± 0.05a0.18 ± 0.05
C24:14.98 ± 0.694.86 ± 0.634.87 ± 0.864.58 ± 0.67
Total20.49 ± 1.98a20.9 3± 1.13a20.16 ± 2.2919.31 ± 1.02
PUFA
Omega 3 PUFA7.84 ± 1.71b7.92 ± 1.74a7.80 ± 1.74b9.45 ± 1.30
C18:3n30.16 ± 0.050.18 ± 0.060.14 ± 0.040.15 ± 0.03
C20:5n30.91 ± 0.460.94 ± 0.460.82 ± 0.421.02 ± 0.4
C22:5n32.21 ± 0.33a2.29 ± 0.362.17 ± 0.32a2.39 ± 0.29
C22:6n34.61 ± 1.12b4.50 ± 1.12b4.67 ± 1.14b5.89 ± 0.81
Omega 6 PUFA26.99 ± 1.9926.89 ± 1.4027.51 ± 2.1727.93 ± 1.58
C18:2n6c10.16 ± 1.2410.07 ± 1.0110.43 ± 1.4310.18 ± 1.27
C18:3n60.05 ± 0.02b0.05 ± 0.02b0.04 ± 0.02a0.03 ± 0.01
C20:3n61.44 ± 0.26a1.49 ± 0.271.41 ± 0.251.32 ± 0.34
C20:4n612.94 ± 1.06a12.82 ± 0.82a13.01 ± 1.18a13.64 ± 0.99
C22:4n62.48 ± 0.582.46 ± 0.352.62 ± 0.602.63 ± 0.50
C16:3n40.05 ± 0.02a0.04 ± 0.02b0.06 ± 0.020.06 ± 0.02
C20:20.28 ± 0.06a0.27 ± 0.050.29 ± 0.06a0.25 ± 0.03
C22:20.05 ± 0.020.05 ± 0.010.06 ± 0.020.05 ± 0.02
Total PUFA35.51 ± 1.95b35.17 ± 1.37b35.71 ± 2.21b37.34 ± 1.30
Table 3 Percentages of fatty acids
Nonalcoholic
Control
Severe APMild AP
C20:00.32 ± 0.09d0.39 ± 0.090.40 ± 0.06
C20:4n612.89 ± 0.83c13.09 ± 1.4013.64 ± 0.99
SFA43.53 ± 1.2944.54 ± 1.86c43.34 ± 0.90
C18:3n60.04 ± 0.020.05 ± 0.02c0.03 ± 0.01
C18:1n9t0.13 ± 0.040.12 ± 0.07d0.16 ± 0.04
C20:5n31.03 ± 0.560.67 ± 0.18d1.02 ± 0.4
C22:5n32.28 ± 0.222.10 ± 0.36c2.39 ± 0.29
C22:6n35.29 ± 1.024.24 ± 1.05d5.89 ± 0.81
n-3 PUFA8.76 ± 1.73a7.14 ± 1.45d9.45 ± 1.30
Total PUFA36.87 ± 1.62a34.91 ± 2.26d37.34 ± 1.30
SOD385.37 ± 21.37a314.90 ± 86.04d384.88 ± 42.21
GPx12557.07 ± 2836.06a9370.85 ± 2196.13d11649.09 ± 1844.75
PI138.49 ± 10.34ac128.14 ± 10.74d146.19 ± 7.08
UI156.67 ± 7.28ac148.99 ± 8.04d161.70 ± 4.90